Use of a train-of-four ratio of 0.95 versus 0.9 for tracheal extubation: an exploratory analysis of POPULAR data

Br J Anaesth. 2020 Jan;124(1):63-72. doi: 10.1016/j.bja.2019.08.023. Epub 2019 Oct 10.

Abstract

Background: The prospective observational European multicentre cohort study (POPULAR) of postoperative pulmonary complications (NCT01865513) did not demonstrate that adherence to the recommended train-of-four ratio (TOFR) of 0.9 before extubation was associated with better pulmonary outcomes from the first postoperative day up to hospital discharge. We re-analysed the POPULAR data as to whether there existed a better threshold for TOFR recovery before extubation to reduce postoperative pulmonary complications in patients who had quantitative neuromuscular monitoring (87% acceleromyography).

Methods: To identify the optimal TOFR, the complete case cohort of patients with quantitative neuromuscular monitoring (n=3150) was split into several pairs of sub-cohorts related to TOFR values from 0.86 to 0.96; values of 0.97 and higher could not be used as the sub-cohorts were too small. The optimal TOFR was considered to have the lowest P-value from multivariate logistic regression calculated for each of the TOFR values. Data are presented as adjusted absolute risk reduction or median difference with 95% confidence interval.

Results: Extubating patients with TOFR >0.95 rather than >0.9 reduced the adjusted risk of postoperative pulmonary complications by 3.5% (0.7-6.0%) from that reported in POPULAR (11.3%). Increasing the recommended TOFR from 0.9 to 0.95 reduced the adjusted risk by 4.9% (1.2-8.5%). Sub-cohorts resulting from 1:1 propensity score matching revealed that sugammadex had been given in higher doses by 0.30 (0.13-0.48) mg kg-1 in the sub-cohort with TOFR > 0.95.

Conclusions: A post hoc analysis of patients receiving quantitative monitoring of neuromuscular function suggests that postoperative pulmonary complications are reduced for TOFR > 0.95 before tracheal extubation compared with TOFR > 0.9.

Trial registration number: NCT01865513.

Keywords: neuromuscular blocking drug; neuromuscular function monitor; neuromuscular recovery; postoperative pulmonary complications; train-of-four ratio.

Publication types

  • Multicenter Study
  • Observational Study

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Airway Extubation / methods*
  • Anesthesia
  • Cohort Studies
  • Europe
  • Female
  • Humans
  • Intraoperative Neurophysiological Monitoring / methods*
  • Male
  • Middle Aged
  • Neuromuscular Blockade / methods
  • Neuromuscular Blocking Agents
  • Neuromuscular Monitoring / methods*
  • Postoperative Complications / epidemiology
  • Postoperative Complications / prevention & control*
  • Propensity Score
  • Prospective Studies
  • Risk Reduction Behavior
  • Sugammadex
  • Young Adult

Substances

  • Neuromuscular Blocking Agents
  • Sugammadex

Associated data

  • ClinicalTrials.gov/NCT01865513